Health
CHIEF-HF: Heart Failure Symptoms Improved With Canagliflozin in Remote Trial – DocWire News
In a fully remote trial, researchers found that canagliflozin, originally developed to treat type-2 diabetes, appeared to greatly…
In a fully remote trial, researchers found that canagliflozin, originally developed to treat type-2 diabetes, appeared to greatly improve symptoms and quality of life in adults with heart failure, whether or not they also had type 2 diabetes. Findings from…
Continue Reading
-
General20 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General22 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News22 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
General21 hours agoLithium mine closure shines light on Ravensthorpe community’s resilience